NRAS‐mutation(+) CRC significantly correlated with less lymph vessel invasion, occurred preferentially in elder patients and at the distal colon, and showed relatively better prognosis, compared with KRAS‐mutation(+) CRC. This evidence concerns the gene NRAS and colorectal carcinoma.